Skip to content
Whale Atlas — Follow the signal.
Home
FULL RECORDS
Search insider filingsAll Congress filings
MORE TOOLS
WatchlistGold IntelligencePeopleCharts & technicalsCompany financialsOfficial newsMy saved workspace
YOUR RESEARCH
HomeSearch insider filingsAll Congress filings
More research tools
ExploreGold IntelligencePeopleInvestigate an ideaCharts & technicalsMore evidenceCompany financialsOfficial newsMy research & helpWatchlistMy saved workspaceLearn the basicsHow signals workData & coverage
RESOURCES
LearnMethodologyData sources
Built on public evidence.

Primary sources. Clear reasoning.
No black boxes.

Our approach
Public research workspacev1.0

Loading data…Scanning SEC filings…Checking Congress reports…Following the signal…

HomeSearchCongressWatchlist
© 2026 Whale AtlasFree public-filing research. Not financial advice. By using this site you agree to the Terms of Use.
FAQCompare trackersMethodologyData & correctionsTermsPrivacy
Back to Home
B

BCYC

Nasdaq

BICYCLE THERAPEUTICS PLC

Latest disclosureOctober 7, 2026
Insider score Why 0?
0/ 100
Qualifying buys · 30d
$0

0 purchases · 36 sales

Price by TradingViewDelayed quote from TradingView, for viewing only. It does not power Whale Atlas scores or alerts. If the quote does not load, open the TradingView link.

Insider transactions 40

Limited filing history
All40Buying0Selling36Other4
Filters

Last 30 daysNo qualifying insider buying. Sales: $61.18K by 6 insiders.

4 of 40 trades · April 2, 2026 – October 5, 2026Incomplete history: this shows the filings imported so far, not every filing ever made. Dates are trade dates. Filters affect this table only.
Award disclosed

Travis Alvin Thompson

Chief Financial Officer

Employee Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded July 15, 2026Filed July 17, 2026SEC filing
Award disclosed

Michael Charles Ferguson Hannay

CHIEF PROD & SUPPLY CHAIN OFF

Employee Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded July 15, 2026Filed July 17, 2026SEC filing
Award disclosed

Michael Skynner

CHIEF SCIENTIFIC OFFICER

Employee Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded July 15, 2026Filed July 17, 2026SEC filing
Award disclosed

Jennifer Scott Perry

Chief Operating Officer

Employee Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context
Non-cash award
Reported price
Award · no purchase price
Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Traded July 15, 2026Filed July 17, 2026SEC filing
Reporting insiderSecurity / transactionAmount / priceValueTraded / disclosedSource
Chief Financial OfficerEmployee Stock Option (right to buy)Grant or awardDerivative units60,000Award · no purchase priceNon-cash awardJul 15Filed Jul 17 · 2d laterSEC filing
CHIEF PROD & SUPPLY CHAIN OFFEmployee Stock Option (right to buy)Grant or awardDerivative units60,000Award · no purchase priceNon-cash awardJul 15Filed Jul 17 · 2d laterSEC filing
CHIEF SCIENTIFIC OFFICEREmployee Stock Option (right to buy)Grant or awardDerivative units60,000Award · no purchase priceNon-cash awardJul 15Filed Jul 17 · 2d laterSEC filing
Chief Operating OfficerEmployee Stock Option (right to buy)Grant or awardDerivative units60,000Award · no purchase priceNon-cash awardJul 15Filed Jul 17 · 2d laterSEC filing

Congress transactions 0

All Congress filings
No disclosed congressional trades for BCYC in the imported filings.

This reflects the filings imported so far, not a complete trading history.

Explore furtherTechnical lab Company financials Test a strategy Compare company

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage
Source
SEC EDGAR · Form 4
Issuer CIK
0001761612
Latest public acceptance
Oct 7, 2026, 10:24 PM UTC
Score calculated
Oct 7, 2026, 10:28 PM UTC
Parser
form4-parser-1.5
Classifier
form4-classifier-1.1
Scoring methodology
insider-experimental-1.1
Availability
Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.